ea0089c32 | Clinical – Surgery/Applied Pathology | NANETS2022
Ziogas, MD, MPH Ioannis A.
, T. Tasoudis, MD Panagiotis
, C. Borbon, MD Luis
, K. Sherman, MD, FACS Scott
, J. Breheny, MS, PhD Patrick
, Chandrasekharan, MBBS Chandrikha
, S. Dillon, MD Joseph
, M. Bellizzi, MD Andrew
, R. Howe, MD, FACS James
Background: Grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are rare, aggressive tumors with poor prognosis. The WHO 2017 classification further subdivided G3 NENs into G3 neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs). Current guidelines favor medical management in most of these patients, and the role of surgical management is not well-defined. We performed a systematic literature review and meta-analysis of surgical management vs ...